Top Markets
Coin of the day
FluoroPharma Medical, Inc. FluoroPharma Medical, Inc.

FluoroPharma Medical, Inc.

FPMI
주식 순위 #41957
FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the... FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of advanced molecular imaging agents. Initially, its efforts are concentrated on cardiovascular applications within the United States market. The company's pipeline features two notable product candidates: BFPET: An imaging agent designed for stress-testing patients with suspected or confirmed coronary artery disease (CAD), which has successfully completed its Phase I clinical trial. CardioPET: Another molecular imaging agent, currently undergoing a Phase IIa clinical trial. This compound aims to evaluate myocardial blood flow and metabolism in individuals afflicted with CAD. FluoroPharma Medical has established key collaborations, including licensing agreements with Massachusetts General Hospital and Sinotau USA. Furthermore, the company holds clinical research agreements with Pharmaceutical Product Development, LLC, and Cardiovascular Imaging Technologies. Established in 2003, FluoroPharma Medical, Inc. is headquartered in Montclair, New Jersey.
주가
$0.0002
마지막 동기화: 2026-08-11
시가총액
$6.85K
변동 (1일)
0.00%
변동 (1년)
100.00%
국가
US
거래 FluoroPharma Medical, Inc. (FPMI)

카테고리

FluoroPharma Medical, Inc. (FPMI)의 주가 이력
최고 종가: $0.00 (2026-08-01 기준)

최저 종가: $1.49 (2011-05-01 기준)
FluoroPharma Medical, Inc.의 주가 이력 (2011 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 0.00%
2025 100.00%
2024 0.00%
2023 -96.05%
2022 2,428.57%
2021 -96.14%
2020 -17.23%
2019 -95.27%
2018 25.28%
2017 -58.83%
2016 -50.85%
2015 -40.34%
2014 -21.20%
2013 -27.67%
2012 -13.76%
2011 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.52%
KR